WASHINGTON (MedPage Today) -- The FDA approved ketorolac tromethamine (Sprix), a short-term use, intranasal painkiller for moderate to moderately severe pain, for use in patients who require an analgesic at the opioid level...

FDA Approves Intranasal NSAID (click here for the full article at MedPage Today)